Xiao Andrew Y, Kanaan Hassan D, Lai Zongshan, Li Wei, Zhang Ping L
William Beaumont School of Medicine, Oakland University, Rochester, MI, USA.
Beaumont Labs, Division of Anatomic Pathology, Beaumont Health, Royal Oak, MI, USA.
Int Urol Nephrol. 2022 Aug;54(8):1957-1968. doi: 10.1007/s11255-021-03078-0. Epub 2022 Jan 3.
A previous immunofluorescent study suggests that, in collapsing glomerulopathy, most hyperplastic podocytes that stained positively for a progenitor cell marker CD133 are derived from CD133 + parietal epithelial cells. In pathology practice, not all renal biopsies with collapsing glomerulopathy show the typical morphologic features for this entity, which include florid podocyte hyperplasia, collapsing glomerular capillary loops, and cystic tubular dilation. This study was made to determine if CD133 staining using an immunohistochemical method can be used to confirm hyperplastic podocytes and identify extensive acute tubular injury in collapsing glomerulopathy.
Twenty-one collapsing glomerulopathy biopsies were stained for CD133 and compared with 15 biopsies with focal segmental glomerulosclerosis, not otherwise specified (FSGS).
All patients with collapsing glomerulopathy were of African American descent with prominent renal failure and nephrotic range proteinuria. In contrast, the FSGS group consisted of patients from a variety of ethnic backgrounds with nephrotic range proteinuria but relatively low serum creatinine. The striking finding was that all collapsing glomerulopathy cases showed positive CD133 staining in the clusters of hyperplastic podocytes. There was significantly higher CD133-positive staining rate for hyperplastic podocytes (38%) in the glomeruli of the collapsing glomerulopathy group when compared to small clusters of hyperplastic podocytes in the FSGS group (8%). In addition, when compared to the relatively weak CD133 staining in the proximal tubules of the FSGS group, the proximal tubules of the collapsing glomerulopathy group all showed diffuse and strong CD133 staining as a feature of severe acute tubular injury, which corresponded to the high serum creatinine levels in these patients.
Our data indicate that the combination of the distinctive mosaic CD133 staining in hyperplastic podocytes and the diffuse tubular CD133 staining is helpful in supporting a diagnosis of collapsing glomerulopathy.
先前的一项免疫荧光研究表明,在塌陷性肾小球病中,大多数对祖细胞标志物CD133呈阳性染色的增生性足细胞来源于CD133⁺壁层上皮细胞。在病理学实践中,并非所有塌陷性肾小球病的肾活检都显示出该病变的典型形态学特征,这些特征包括明显的足细胞增生、肾小球毛细血管襻塌陷以及肾小管囊性扩张。本研究旨在确定使用免疫组织化学方法进行CD133染色是否可用于确认塌陷性肾小球病中的增生性足细胞并识别广泛的急性肾小管损伤。
对21例塌陷性肾小球病活检标本进行CD133染色,并与15例未另行指定的局灶节段性肾小球硬化(FSGS)活检标本进行比较。
所有塌陷性肾小球病患者均为非裔美国人,有明显的肾衰竭和肾病范围蛋白尿。相比之下,FSGS组由来自各种种族背景、有肾病范围蛋白尿但血清肌酐相对较低的患者组成。显著的发现是,所有塌陷性肾小球病病例在增生性足细胞簇中均显示CD133染色阳性。与FSGS组增生性足细胞小簇(8%)相比,塌陷性肾小球病组肾小球中增生性足细胞的CD133阳性染色率显著更高(38%)。此外,与FSGS组近端小管中相对较弱的CD133染色相比,塌陷性肾小球病组的近端小管均显示弥漫性强CD133染色,这是严重急性肾小管损伤的特征,与这些患者的高血清肌酐水平相对应。
我们的数据表明,增生性足细胞中独特的镶嵌性CD133染色与肾小管弥漫性CD133染色相结合有助于支持塌陷性肾小球病的诊断。